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Bone marrow or stem cell transplantation (BMT) has assumed a growing role in the treatment of a range of pediatric malignancies, hematologic diseases, and metabolic conditions. 1 Important advances in supportive care and donor registries have contributed to improved outcomes and broader utilization. 1, 2 Nevertheless, BMT remains an aggressive treatment that presents considerable burdens for the child and his or her family. [3] [4] [5] Normal school and family activities are disrupted as the family seeks care at specialized centers, often far from their support networks at home. The stress of illness is exacerbated by invasive, uncomfortable procedures (eg, bone marrow biopsies), difficult toxicities (eg, immunosuppression), and elevated risk of complications and medical late effects (eg, chronic GVHD, endocrine disorders, second malignancies). 6 A small but growing database has documented some of the adverse changes in quality of life (QOL) 7, 8 and psychosocial adjustment experienced by many pediatric transplant recipients, both during active treatment 3, 4, 9, [10] [11] [12] and long-term recovery. [13] [14] [15] [16] [17] [18] [19] Although it is evident that children undergoing BMT require a range of supportive care services, there is little information about how these needs are actually addressed across pediatric transplant centers. Are QOL deficits routinely screened in clinical practice, and if so which domains are evaluated and how? For patients with identified needs, what types of supportive care resources are available, and who provides them? Data about these practice patterns would help clarify advances and gaps in the standard of care, and facilitate development of practice guidelines.
Our previous pilot work hinted that paediatric transplant centers rarely make use of screening instruments or referrals to mental health providers (Nieder Adams, unpublished data, 2003). We are aware of no published investigations that have examined supportive care services specifically among pediatric BMT programs. Two studies 20, 21 explored the availability of a number of supportive care services at 39 National Cancer Institute-(NCI) designated cancer centers, and one study 22 examined services at 170 English Health Districts. These studies offer a preliminary portrait of QOL interventions, but none of them focused on QOL screening or early identification of deficits. Moreover, although children were treated at many of these facilities, only one 21 of the three studies distin-guished between services directed toward adults and those for children. Each of these American 20, 21 and British 22 research teams concluded that supportive care services are being developed in a fragmented, poorly coordinated manner. An additional concern was that some services were excessively dependent on the special initiative of one or two staff members rather than part of an integrated policy of care, and thus especially vulnerable to staff turnover or altered fiscal commitments. 21 The current study focused on selected aspects of supportive care at pediatric BMT centers.
In view of the improved disease-free and overall survival experienced by many transplant recipients, there is growing interest in supportive care and QOL during the course of long-term recovery rather than only during the acute treatment period. A number of centers provide extended follow-up care after completion of active treatment, and some centers have established organizationally separate clinics for this purpose. In a recent study of adult survivors of childhood seen at a survivor clinic, QOL screen appeared to be feasible and levels of physical and emotional symptomatology were high. 23 The extent to which followup care is available across centers has both clinical and research implications. Clinically, long-term follow-up services may contribute to early detection and treatment of recurrence late effects, or QOL deficits. In addition, these services have notable ramifications for investigators, because they create access to a potential pool of survivors who might be targeted for studies concerning long-term medical or behavioral sequelae -areas in pressing need of additional research. In the current study, we inquired about the availability and duration of extended follow-up care and obtained initial estimates of retention/attrition rates.
In sum, the purpose of the current descriptive study was to obtain a closer look at some of the dimensions of supportive care provided at pediatric BMT centers. Specifically, we evaluated (1) whether screening was routinely provided for a number of important QOL domains, (2) whether selected psychosocial interventions were available to patients, and (3) whether support services were provided for staff. In addition, we sought information about (4) long-term follow-up care for transplant survivors.
Methods

Procedures and participants
This was a cross-sectional descriptive survey study designed to gain an initial impression about selected supportive care services provided at pediatric BMT centers. We surveyed the centers registered in the Pediatric Blood and Marrow Transplantation Consortium (PBMTC). Between February and September 2003, 79 centers were surveyed via written questionnaires sent to each center's PBMTC-designated principal investigator. Up to three reminder notices were sent to nonresponders. The initial study announcement and the first reminder notice were sent via electronic mail by the PBMTC administrator; subsequent contacts due to nonresponse or missing/ambiguous data were made directly by the research team. The response rate was 82.2% (n ¼ 65 centers). Characteristics of the participating centers are listed in Table 1 . The sample incorporated a range of academically-affiliated and community-based programs, and the number of pediatric transplants performed per year was highly variable (median ¼ 20; range 0-115).
The PBMTC is an international multi-institutional organization whose purpose is to engage in scientific and educational activities related to hematopoietic stem cells for treatment of children and adolescents. It is a non-for-profit organization affiliated with the Children's Oncology Group and with the NIH Stem Cell Transplant Clinical Trials Network. Group protocols are formulated within strategy groups, which include oncologic diseases; immunologic and metabolic disorders; bone marrow failure and hematologic disorders; stem cell sources; supportive care; and GVHD; there are also committees concerning clinical practice guidelines and nursing. The current project was approved by the Supportive Care Strategy Group.
Survey instrument
A brief 21-item survey was generated by the research team. Item construction was informed in part by previous supportive care surveys 20, 22 and by interdisciplinary collaboration among the team's hematologist-oncologists, nurses, and behavioral scientists to enhance content validity, but with an emphasis on brevity and ease of administration. The instrument encompassed four selected components of pediatric supportive care, including (1) QOL screening, (2) psychosocial interventions, (3) support services for staff, and (4) long-term follow-up care. Specifically, respondents were asked whether routine screening is provided for a number of important QOL domains (ie, psychosocial distress, cognitive deficits, pain, fatigue, sleep impairment, spiritual concerns); what assessment modalities are used (ie, interview, standardized measures, others); and who provides assessments for psychosocial difficulties (eg, nurse, social worker, psychologist, child life specialist, psychiatrist, etc). With respect to psychosocial interventions, respondents provided information about the availability of pediatric support groups and arts-in-medicine programs (eg, art or music therapy). Information was obtained about whether staff members were assessed for burn-out, and whether programs were available to prevent staff stress and burn-out. Additional items inquired whether patients received extended follow-up 
Statistical analyses
Descriptive statistics were used to summarize responses. w 2 analyses or Fisher's exact test were used to assess whether supportive care services were associated with the nature of the program (academic vs community-based) or with its size (median split for annual number of transplants). P-values less than 0.05 were considered significant. Table 2 lists the percent of centers that provided routine screening for all pediatric transplant patients across a number of QOL domains. Psychosocial distress and pain were routinely screened by roughly four out of five participating centers (78.5-80.0%). Fatigue was assessed by 69.2% of centers. Cognitive deficits, sleep disturbance, and spiritual concerns were screened less frequently (38.5-60.0%). Relative to academic centers, communitybased centers were significantly more likely to assess sleep deficits (Po0.05), and marginally more likely to screen pain (P ¼ 0.055) and fatigue (P ¼ 0.09). QOL screening was not significantly associated with the size of the facility (as indicated by the annual number of transplants). Table 2 also lists the assessment modalities used to evaluate QOL. Screening was typically conducted via interview or physical exam; standardized screening measures were used infrequently.
Results
QOL screening
Psychosocial concerns were typically screened by psychologists or neuropsychologists (31.4%), social workers (31.4%), or combined teams of psychologists and social workers (11.8%), sometimes supplemented by nurses (5.9%). Table 3 notes the proportion of centers that provided selected psychosocial support services to pediatric patients, and that offered support services to staff. Respondents reported moderate availability of support groups and arts-in-medicine programs (eg, art or music therapy) for patients, and limited provision of services for staff. The availability of these services was not significantly associated with characteristics of the treatment center (ie, annual number of transplants or academic-vs-community-based facility).
QOL interventions
Long-term follow-up
Almost all participating centers (98.5%) reported providing extended follow-up to patients after completion of treatment. Table 4 lists the proportion of treated patients successfully retained for long-term follow-up, and the age through which follow-up continued. Most centers (71.9%) reported retention rates of at least 70%. However, the target age through which patients were followed was highly variable: 45.4% of centers ceased follow-up by age 21 or earlier, while 40.6% continued to monitor patients indefinitely. Some centers offered an organizationally separate follow-up clinic (42.2%), though in most centers follow-up care was integrated into regular clinic services.
Discussion
Despite the burdens of treatment, supportive care services have not always received the attention they merit in oncology settings. 24 Depression and other emotional difficulties have traditionally been underdiagnosed and undertreated. 25 Pain control is often suboptimal, 26, 27 notwithstanding extensive efforts to disseminate practice guidelines. 28, 29 Similarly, fatigue, 30,31 nutritional deficits, 32 and sleep disturbance 33, 34 are common concerns that may be overlooked until they reach severe levels of acuity. Ineffective management of these symptoms, alone or in 24, [35] [36] [37] The National Comprehensive Cancer Network guidelines call for routine screening and early intervention for a number of negative sequelae such as emotional distress, 38 fatigue, 39 and pain. 28 How well do pediatric BMT centers address these concerns?
The current study offers a preliminary picture of practice patterns across pediatric BMT centers. Results suggest that, during active treatment, screening is common for some QOL domains, such as psychosocial distress and pain, though there is room for improvement. Approximately 80% of centers provided routine evaluation for these difficulties. Screening is less consistent in other domains, such as cognitive deficits (52%), sleep disturbance (60%), and fatigue (69%). Descriptive studies would help clarify the prevalence and chronicity of these difficulties, specifically among pediatric BMT recipients with different diseases receiving different treatment regimens; in the interim, concerns about fatigue, 30, 31 sleep disturbance, 33, 34 and cognitive difficulties, at least among very young patients, 18, 19 would seem to warrant more consistent screening.
For the most part, screening was conducted through use of interviews or medical exams. A growing number of validated QOL measures are now available for use with pediatric patients (eg, Behavioral, Affective and Somatic Experiences Scale, 40 Pediatric Quality of Life Inventory 41 ), and provide important information from the perspective of the child and parent(s). Current findings indicate that these are rarely used in clinical practice. Inclusion of standardized measures would help identify common difficulties, clarify base rates, allow comparisons across centers, and provide baselines against which to measure changes over the course of treatment. Moreover, early identification of these difficulties may help treatment centers develop more effective interventions. Of course, cost, feasibility, and psychometric soundness are considerations in selecting screening measures. However, brief, practical instruments are being used with growing frequency in oncology settings; additional efforts to validate and disseminate concise screening tools in pediatric centers would be helpful.
With respect to psychosocial interventions, most centers appear to provide counseling resources for patients with identified adjustment difficulties. The availability of other treatment modalities was more limited. Support groups were provided by 60% of centers and arts-in-medicine programs (eg, art or music therapy) by 49%. Findings seem to parallel those of a previous study that focused on cognitive-behavioral interventions for procedure-related pain, which suggested that these services are growing but underutilized in pediatric oncology settings. 42 Staff too may experience personal challenges in working with children undergoing aggressive treatment for lifethreatening illnesses; clinicians may struggle with grief, over-identification, defensive withdrawal or emotional depletion. [43] [44] [45] Despite the demanding nature of clinical care, few pediatric transplant centers provided systematic assessment (34%) or prevention (34%) regarding staff burnout. Additional attention might be directed toward these concerns.
Contrary to our expectations, the size of the transplant program (as reflected by the annual number of transplants) was not associated with QOL screening or psychosocial interventions; we had anticipated that larger programs might be better positioned to offer these services. Interestingly, screening for a number of QOL deficits was marginally more common among community-based as opposed to academic centers.
In addition to evaluating supportive care services during active treatment, the current study examined the availability of long-term follow-up care. The number of centers providing extended follow-up for transplant survivors is heartening and suggests that research on late effects and long-term QOL outcomes may be feasible, at least through young adulthood. Reaching survivors who have grown into their 30s or beyond is apt to be much more challenging. Initial estimates of the proportion of patients successfully retained through extended follow-up were fairly high. If substantiated, these estimates bode well for future research -they imply that follow-up clinics will not generate samples that are severely hampered by attrition and selection bias.
To our knowledge, this is the first investigation to focus specifically on supportive care screening, interventions, and follow-up care in the pediatric BMT setting. Nevertheless, this preliminary project has a number of important limitations. Findings were obtained from a broad range of pediatric transplant programs, both large and small, academically affiliated and community based; however, it is unclear whether results would generalize to centers outside the PBMTC. It is possible that our results may reflect an upper limit estimate or optimistic impression regarding the availability of support services in pediatric transplant centers. The survey instrument was developed by the investigators drawing in part on prior supportive care studies, 20, 22 but it is a simple mailed survey rather than a standardized measure and its psychometric properties are unknown. In particular, the instrument was designed to be as brief as possible in order to maximize the response rate; hence, several areas of interest were omitted and merit attention in future research (eg, in-house services vs external referrals; screening of nutritional status; specific interventions for management of pain and fatigue; provision Table 4 Extended follow-up offered by pediatric transplant centers Notwithstanding these limitations, current findings suggest that supportive care services might be enhanced by more consistent screening across a range of QOL domains (especially sleep disturbance and cognitive deficits), and by supplementing information from interviews or medical exams with data from standardized measures that capture the perspective of the child and/or parent. In turn, psychosocial interventions for children might be enriched by inclusion of additional treatment modalities (eg, groups, art or music therapy). Further consideration also should be directed toward support services for medical staff. Overall, as others have argued, 46 the availability of supportive care services would be enhanced by greater efforts to develop practice guidelines, staff training, and partnerships with family advocates.
Finally, there is a pressing need for additional research concerning long-term medical and behavioral outcomes among pediatric BMT recipients. 3, 6 Current results suggest that follow-up clinics may offer a feasible mechanism to support these investigations, in order to clarify needs and refine interventions.
